Sean Brynjelsen Net Worth & Insider Trades
Sean Brynjelsen - President & CEO, Eton Pharmaceuticals, Inc
What is Sean Brynjelsen's Net Worth?
The current estimated net worth of Eton Pharmaceuticals, Inc's President & CEO, Sean Brynjelsen, is estimated to be about $39.58M . Sean Brynjelsen owns about 1,064,940 units of Eton Pharmaceuticals, Inc common stock. In the last 5 years at Eton Pharmaceuticals, Inc, Sean Brynjelsen has sold an estimated value of $0 worth.
What is Sean Brynjelsen's Past Insider Trading?
Sean Brynjelsen's largest purchase order was 10,000 units , worth over $79.33K on May 22, 2019. In total, Sean Brynjelsen has made about 12 transactions over 5 years of their time at Eton Pharmaceuticals, Inc. Sean Brynjelsen usually trades in March, with the busiest year in 2021, 2019 and 2022. The most recent transaction was a purchase order of 10,000 units , worth over $21.04K on September 23, 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SEAN BRYNJELSEN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Sean Brynjelsen's Salary in 2020?
As President & CEO of Eton Pharmaceuticals, Inc, Sean Brynjelsen has a total base salary of $475,833 . Sean Brynjelsen received compensation valued at about $2,011,293 in 2020 after becoming President & CEO. The vast majority of their compensation came in the form of other earnings, plans or compensations of $218,700 , option awards of $1,305,360 , and other compensation of $11,400 .
What is Sean Brynjelsen's' Mailing Address?
- Mailing address is C/o Eton Pharmaceuticals, Inc. 21925 W Field Pkwy #235 Deer Park IL 60010 IL
Eton Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Sean E. Brynjelsen | 2020 | $475,833 | $218,700 | - | $1,305,360 | $11,400 | $2,011,293 |
| Sean E. Brynjelsen | 2019 | $409,958 | $186,500 | - | $1,338,750 | $11,200 | $1,946,408 |
| W. Wilson Troutman | 2020 | $277,083 | $108,000 | - | $509,629 | $11,400 | $906,112 |
| W. Wilson Troutman | 2019 | $242,667 | $87,500 | - | $523,260 | $11,200 | $864,627 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1710340/000149315221009679/formdef14a.htm
What are Eton Pharmaceuticals, Inc's Past Insider Trades?
Eton Pharmaceuticals, Inc's most recent insider trade came on September 23, 2022 by Sean Brynjelsen who bought 10,000 units worth $21.04K . In the last 4 years, insiders at Eton Pharmaceuticals, Inc have sold an estimated value of $20.77M and bought an estimated value of $3.29M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Sean Brynjelsen, President & CEO, Opaleye Management Inc, and Charles Casamento, Director .
Eton Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||